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1. Introduction
  Tuberculosis (TB) is an airborne infectious disease that 
is preventable and curable. But it still remains as a major 
predicament to intercontinental health systems. As per 
global tuberculosis control - a short update to the 2009 
report[1]; World Health Organization (WHO) estimated 9.4 
million incident cases of TB globally in 2008, most of which 
occurred in Asia (55%) and Africa (30%). But the number of 
notified cases of TB in 2008 was only 5.7 million, equivalent 
to 55-67% of all incident cases. India and China alone 
account for an estimated 35% of TB cases worldwide. Among 
these new cases around 15% were human immunodeficiency 
virus (HIV) positive. Despite widespread introduction of the 
Directly Observed Therapy Short-course (DOTS) program for 
TB, incidence of the disease continues to rise, exacerbated 
by high levels of HIV[1]. Latent TB is another burden on TB 
control programme. The control of TB depends on early 
detection and effective treatment[2, 3].  Diagnosis of TB using 
acid-fast staining of sputum smear and standard culture is 
considered as the gold standard, but it miss a large number 
of cases because of handling problem and lack of good 
sensitivity (sensitivity 40-75%)[4]. Clinicians either have to 
treat based on clinical judgment or wait for culture results, 
which may take up to 6 weeks[5, 6]. Empirical treatment 
increases public health expenditure and the risk of drug 
side-effects that may be fatal[7]. Nucleic acid amplification 
test seems to help in the diagnosis of TB[8]. However, this 
technique is expensive, requires special expertise and 
equipments. Excessive delays in correct TB diagnosis 
and treatment remain a weakness of the control strategy. 
Such delays are critical as infectious individuals provide 
more opportunities for transmission of the disease. Hence, 
there is an urgent need for improved and easily accessible 
diagnostic methods that are simple, rapid, inexpensive, 
reliable and suitable for use in the developing world.  
  Serological tests are simple to use and inexpensive. As they 
do not depend on the site of infection, serological tests may 
be better for detecting EPTB and for children or uncooperative 
patients, among whom collection of clinical samples may 
be difficult. In earlier studies from our laboratory, we have 
shown diagnostic usefulness of Mycobacterium tuberculosis 
(M. tuberculosis), excretory secretory (ES) antigens ES-31, ES-
41 and ES-43 in antibody detection by penicillinase ELISA 
(Pen-ELISA[9-12]. Antigen EST-6 containing 38 kDa and 41 
kDa proteins was also explored for antibody detection by 
Pen-ELISA[13]. A cocktail of ES-31, ES-41 and ES-43 antigens 
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had shown improved sensitivity of Pen-ELISA compared 
to single ES-31 antigen in antibody detection in PTB [14]. 
Further, a cocktail of affinity purified antibodies against 
ES-31, ES-43 and EST-6 antigens was explored for circulating 
free and immune complexed (IC) antigen detection in TB by 
sandwich ELISA[15]. The usefulness of inhouse developed 
penicillinase ELISA using cocktail of antigens (ES-31, ES-
43 and EST-6 antigens) and their immunoglobulins was also 
shown in a prospective study which was carried out at a 
tertiary care hospital located in rural area[16]. All these 
assays were based on penicillinase ELISA, which is sensitive 
but semi-quantitative and subjective assay. Microtitre plate 
peroxidase sandwich ELISA for detection and quantitation of 
circulating free and IC ES-31 antigen was also shown to be 
useful in diagnosis of PTB cases[17]. Mass screening suitable, 
user friendly SEVA TB peroxidase enzyme immunoassay was 
developed using cocktail of antigens (ES-31, ES-43 and EST-6 
antigens) and their immunoglobulins for the detection of 
TB cases[18].  In the present study, this inhouse developed 
SEVA TB peroxidase enzyme immunoassay was analyzed 
prospectively to find its usefulness in suspected TB cases in 
tertiary hospital located in a rural area. 
2. Materials and methods
2.1. Patients and clinical case selection 
  The present prospective study was carried out during 
November 2008 ~ March 2009. Patients attending Kasturba 
Hospital of Mahatma Gandhi Institute of Medical Sciences 
(Tertiary hospital), Sevagram, located in rural India, who 
were suspected of having TB on clinical examinations and 
other laboratory investigations participated in the present 
study. Sera samples were received from 119 patients, out 
of which 73 were suspected for having PTB while 46 for 
EPTB.  EPTB included bone and joint TB (29), tuberculous 
lymphadenopathy (7), genitourinary TB (4), abdominal TB (3), 
ocular TB (1) and tuberculous meningitis (1). Data of their 
acid fast bacilli (AFB) status and antituberculosis therapy 
(ATT) was collected. 
  Sera samples were stored at our Center’s sera bank in 0.5 
mL aliquots at -20 ℃ with 0.1% sodium azide until use. All 
cases included in this study had history of BCG vaccination. 
Each sera sample was assayed for presence of cocktail 
antibody, circulating or IC-cocktail antigen as described 
above. 
  Clinical history, physical examination, baseline laboratory 
investigations (hemogram, tuberculin skin test, chest 
skigram, urinanalysis), microbiological (AFB smear and 
culture), histological and cytological (FNAC) investigations, 
ultrasound or computerized tomographic scanning (CT) 
depending upon the location of the infection in patients, 
clinicians high degree of suspicion of TB depending on 
clinical sign and symptoms and response to ATT treatment 
were considered as the basis for selection of cases. 
  The study was done prospectively in blinded manner in 
which clinical diagnosis was not available to the laboratory 
personnel prior to the assay. In the present study, each 
serum sample had been assayed in duplicate.  
2.2. Isolation of M. tuberculosis, ES-31, ES-43 and EST-6 
antigens and their antibodies
  ES-31 antigen was isolated from M. tuberculosis H37Ra ES 
antigen by affinity chromatography using anti ES-31 antibody 
coupled sepharose-4B column (Pharmacia Biotechnology AB, 
Uppsala, Sweden) [19]. Briefly, cyanogen bromide-activated 
sepharose-4B beads were coupled with purified anti ES-
31 antibody. detergent soluble sonicate (DSS) antigen was 
passed through column and ES-31 antigen was eluted by 
Glycine HCl buffer (0.01 mol/ L, pH2.5) and collected in Tris-
HCl buffer (0.01M, pH8.6). Similarly ES-43 and EST-6 were 
isolated by affinity chromatography using anti ES-43 or anti-
EST-6 antibody coupled sepharose-4B column. Cocktail 
antigen (ES-31, ES-43 and EST-6) was prepared by mixing the 
individual antigen in equal proportion.
  M. tuberculosis H37Ra DSS antigen, was prepared from M. 
tuberculosis H37Ra bacilli.  Briefly, bacilli were 5% phenol 
inactivated in 0.5 M phosphate buffer (PBS, pH7.2) and 
incubated with sodium dodecyl sulphate (SDS) extraction 
buffer. The supernatant as dialysed against 0.01M PBS, pH 7.2 
and used as an antigen source [15]. Anti-DSS IgG antibodies 
were raised in goat by immunizing intramuscularly with 500 
毺g protein/mL DSS antigen with 1 mL Freund’s incomplete 
adjuvant on day 0, 20, 33 and 45. Immune sera were collected 
on day 32, 44, 57, 60 and thereafter fortnightly and anti-
SDS IgG was isolated by 33% saturation with ammonium 
sulphate under ice, followed by diethyl aminoethyl-
cellulose ion exchange column chromatography as described 
earlier[20]. Anti-ES-31, anti-ES-43 and anti-EST-6 antibodies 
were isolated from anti-DSS IgG by affinity chromatography 
using ES-31, ES-43 or EST-6 antigen coupled sepharose-4B 
column [20]. Anti-cocktail antibody (anti-ES-31, anti-ES-43 
and anti-EST-6) was prepared by mixing individual antibody 
in equal proportion[19]. 
2.3. SEVA TB peroxidase enzyme immunoassay for cocktail 
antibody, circulating free and IC-antigen
  Indirect peroxidase ELISA was performed for detection of 
antibody using cocktail antigen (ES-31, ES-43 and EST-6). The 
wells of ELISA plates (NUNC) were sensitized with optimally 
diluted concentration of cocktail antigen 3 毺g / 100 毺L/well 
in 0.06 M carbonate buffer pH9.6 overnight at 4 ℃, followed by 
blocking with BSA 1% for 2 hours at 37 ℃. Plate was washed 
twice with PBS containing 0.05% Tween 20 (PBS/T) followed 
by addition of sera (dilution 1:50) in PBS/T for 1 hour at 37 
℃, then washed 3 times. After that the wells were exposed 
to 1:1000 diluted anti-human IgG peroxidase conjugate for 
1 hour at 37 ℃. The wells were washed five times with PBS/T 
with 1 minute interval. The color was developed using TMB 
substrate (20伊 concentration) followed by using 50 毺L stop 
solution (2N H2SO4). Then mean optical density at 450 nm was 
read with ELISA reader. 
  The detection of circulating cocktail antigen (ES-31, ES-
43 and EST-6) using affinity purified anti-cocktail antibody 
(anti-ES-31, anti-ES-43 and anti-EST-6) was performed by 
sandwich plate peroxidase ELISA. The procedure was the 
same as that of indirect peroxidase ELISA mentioned above. 
The anti-cocktail antibody filled in the ELISA wells was 50 
毺g / 100 毺L/well, and the wells were finally exposed to 
1:1000 diluted goat anti-cocktail antibody IgG peroxidase 
conjugate. 
  For detecting IC antigen, serum samples were pretreated 
with Glycine-Hcl buffer (0.1 mol/L) followed by heating at 65 曟 
for 15 minutes.
3. Results
  During the prospective study, 119 suspected TB patients 
were screened for the presence of antibody, circulating free 
and immune complexed cocktail antigens in the sera by 
peroxidase immunoassay (Table 1). Sera showing presence of 
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antibody or antigen or IC-antigen, are considered as ELISA 
positive. 
  There were a total of 73 suspected PTB cases, of which 15 
were screened for presence of AFB, but none was positive. Of 
the 46 suspected EPTB cases, 3 were screened for presence of 
AFB, only one was positive (It was also ELISA positive). Four 
of the PTB cases and 7 of the EPTB cases were administered 
with ATT on the basis of sputum/culture or other clinical 
investigations and all of these cases showed ELISA positivity. 
Thus, assay showed 100% correlation between acid fast 
bacilli positivity and antitubercular treatment. 39 PTB cases 
and 12 EPTB cases showed negative ELISA and these cases 
were not given ATT. 30 PTB and 27 EPTB cases were neither 
AFB positive nor ATT treated, but these cases showed ELISA 
positivity.  
  Of the 29 suspected cases of bone and joint TB cases 
screened, 23 cases were ELISA positive. However only 6 were 
administered with ATT, 3 of the 6 were ELISA positive as well 
as ATT treated but they were negative for AFB, histopathology 
and FNAC (Cytology) for tubercular pathology. In these cases, 
strong clinical suspicion was correlated with ELISA positivity. 
Out of 7 suspected lymphnode TB cases screened, 6 were 
ELISA positive, and 1 was also positive on FNAC (Cytology) for 
tubercular pathology, however none of the seven cases were 
administered with ATT. Two of the 4 genitourinary cases, 1 
of the 3 abdominal,1 of 2 ocular TB cases were ELISA positive 
but not ATT treated. One case of TB meningitis showed ELISA 
positivity and was ATT treated.
4. Discussion
  In current clinical practice, the diagnosis of TB depends on 
clinical findings and various laboratory tests. Although AFB 
smear microscopy and culture are valuable for confirmative 
diagnosis of TB; low bacillary load and extent of TB disease 
at extrapulmonary site of the infection do make the AFB test 
not reliable. Further, it is very difficult to obtain sputum 
specimen in children. Based on no proper history of BCG 
vaccination, evening rise of fever, sweating, loss of appetite 
etc and ruling out other causes children are suspected of 
having TB Meningitis. Therefore immunodiagnosis seems 
to be ideally suited as a diagnostic method. Serodiagnostic 
test like ELISA can show promise because of its ease of 
performance in field laboratories and cost-effectiveness. 
Over a decade, our laboratory reported usefulness of various 
mycobacterial excretory secretory antigens in the diagnosis 
of TB by penicillinase enzyme immunoassay. Assay for 
detection of free circulating cocktail antigen (ES-31, ES-43 
and EST-6) by SEVA TB penicillinase ELISA was found useful 
for PTB cases with 91% sensitivity and 97% specificity for 
sputum positive AFB positive cases and also useful in 
detection of EPTB cases[15, 21].  But, the penicillinase assay is 
subjective and semiquantitative. User friendly, quantitative 
microtitre plate peroxidase sandwich ELISA was explored by 
using affinity purified anti ES-31 antibody for detection of 
circulating antigen in TB sera[17]. SEVA TB Peroxidase enzyme 
immunoassay was shown 80% sensitivity and 90% specificity 
for detection of PTB cases and proven the usefulness of assay 
of cocktail antigen over assay for single antigen. This assay 
showed a sensitivity for detection of very low concentration 
of cocktail antigen (0.25 毺g/ mL cocktail antigen) [18].
  In this tertiary hospital located in rural area, patients 
usually visit with chronic symptoms or progressive TB 
disease. Clinicians send samples for testing on clinical 
suspicion based on some clinical signs. In the present 
study, the inhouse developed SEVA TB peroxidase enzyme 
immunoassay was evaluated prospectively. Enzyme 
immunoassay showed 100% correlation with AFB positivity 
as well as with ATT treated cases of PTB and EPTB. Seven 
ATT treated EPTB (Bone and joint and TB Meningitis) cases 
showed ELISA positivity. This may be due to presence of 
tubercular foci at extrapulmonary sites. Thus in ATT treated 
AFB negative cases, ELISA positivity can be correlated with 
histopathological, FNAC or radiological findings and supports 
the clinical diagnosis. It is of interest that peroxidase assay 
could detect antigen in AFB negative but clinically diagnosed 
and ATT treated cases. In AFB negative patients; though 
bacillemia is low, antigen level is significant, possibly due 
to antigen released by death of bacilli or slow clearance of 
antigen in these patients. This needs further extensive study 
of AFB negative clinically suspected and ATT responding PTB 
& EPTB cases.
  Thirty PTB and 27 EPTB cases were neither AFB positive nor 
ATT treated, but these cases showed ELISA positivity. The 
probable reason of this finding might be the low sensitivity 
of sputum microscopy and mycobacterial culture[7]. At 
concentrations below 1 000 organisms per mL of sputum, the 
chance of observing bacilli in a smear becomes less than 
10% while detection limit of mycobacterial culture is around 
100 organisms per mL[22]. Even the smear examinations has 
proven less sensitive in HIV-TB coinfection due to absence of 
cavity formation secondary to poor immune status, resulting 
in lower bacillary count. Expanded case definition and 
response to treatment (RTT) have been advocated to enhance 
the diagnosis of PTB and EPTB in HIV infected adults in 
resource limited settings[23, 24]. The reason behind positivity 
of ELISA in these cases might have indicated presence of 
latent TB. Such cases need further follow-up for showing 
clinical disease if any in due course of time. 
  The diagnosis in AFB negative PTB and EPTB cases is 
difficult. Most of the EPTB cases are AFB negative as proper 
tissue sample or fluid is not available for AFB testing. Such 
cases may not show presence of AFB, but on histopathology 
Table 1
Immunoscreening of suspected cases of tuberculosis attending tertiary care hospital during November 2008 to March 2009.  
Group
Total No. screened ATT Treated No ATT
ELISA positve ELISA negative ELISA positive ELISA negative
PTB 73 4 0 30 39
EPTB 46 7 0 27 12
Bone and Joint TB 29 6 0 17   6
Lymphnode TB      7 0 0   6    1
Genitourinary   TB                        4 0 0   2    2
Abdominal TB       3 0 0   1    2
Ocular TB 2 0 0   1    1
TB Meningitis                1 1 0   0    0
ELISA test positivity either for antibody or free antigen or immune-complexed antigen is considered ELISA positive.
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or FNAC, tubercular pathology can be seen. Usually the 
classical symptoms or signs sugges¬tive of TB such as a 
productive cough for more than 2 weeks, which may be 
accompanied by other respiratory symptoms (shortness 
of breath, chest pains, haemoptysis) and/or constitutional 
symptoms (loss of appetite, weight loss, fever, night 
sweats and fatigue) are not present in EPTB cases[25].Based 
on presentation of chronic fever, pain in joints, lesions 
etc and ruling out other causes patients are suspected 
of bone & joint TB. Instead of starting ATT in these AFB 
negative cases, often clinicians prescribe broad-spectrum 
antibiot¬ics (excluding anti-TB drugs and fluoroquinolones 
and aminoglycosides) for 4 to 6 weeks. If patient does not 
respond then as per WHO guidelines, clinicians prescribe 
ATT considering the case as AFB negative but clinically 
suggestive[25]. Such delay frequently made on circumstantial 
evidence alone and hindrance in diagnosis might have 
life threatening consequences. In such AFB negative PTB 
and EPTB cases, serodiagnostic tests may act as supportive 
substantiation for starting of ATT. However extensive study 
and follow up on more suspected patients is needed.
  Thus, this inhouse developed less expensive, user-friendly 
peroxidase ELISA may be used as adjunct test of smear 
microscopy or culture techniques for routine screening of 
patients suspected of PTB as well as EPTB cases.
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